SBIR/STTR Research Award

IMMUNOLOGICAL AND DNA HYBRIDIZATION ASSAYS WHICH EMPLOY SPECIFIC ANTIBODY AND DNA PROBES ARE PROVING TO BE VERY VALUABLE IN THE IDENTIFICATION OF PATHOGENS AND IN THE DIAGNOSIS OF GENETIC DISEASES.

Award identifier 196612cf6793bfc98b918f5e09008cef1a6637b0f939fde7014b112ed63a41f9Awarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1985

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
Agouron Pharmaceuticals Inc.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

IMMUNOLOGICAL AND DNA HYBRIDIZATION ASSAYS WHICH EMPLOY SPECIFIC ANTIBODY AND DNA PROBES ARE PROVING TO BE VERY VALUABLE IN THE IDENTIFICATION OF PATHOGENS AND IN THE DIAGNOSIS OF GENETIC DISEASES. THE OBJECTIVE OF THIS PROJECT IS TO IMPROVE THE SENSITIVITY, SAFETY, AND CONVENIENCE OF DIAGNOSTIC TESTS BY DEVELOPING A NONRADIOACTIVE, LUCIFERASE BASED PROBE TECHNIQUE. TO EVALUATE THE USEFULNESS OF LIGHT EMISSION AS A SIGNAL IN IMMUNOLOGICAL AND DNA HYBRIDIZATION ASSAYS, THE LUCIFERASE PROTEIN FROM A MARINE CRUSTACEAN WILL BE CONJUGATED TO ANTIBODY AND OLIGONUCLEOTIDE DNA. USE OF LUCIFERASE WOULD AVOID THE HAZARDS ASSOCIATED WITH RADIOISOTOPES, AND LIGHT PRODUCTION IS CONVENIENT TO MEASURE. THE PROBE SIGNAL CAN BE GREATLY AMPLIFIED IN COMPARISON TO RADIOISOTOPE DECAY SINCE LIGHT IS THE PRODUCT OF AN ENZYMATIC REACTION. IN PHASE I, METHODS TO COVALENTLY LINK LUCIFERASE TO PROTEIN AND DNA WILL BE EVALUATED, AND SEVERAL PROTOTYPIC ASSAYS INCORPORATING LUCIFERASE CONJUGATES WILL BE DESIGNED. SHOULD A LUCIFERASE PROBE PROVE TO GENERATE A SIGNAL WHICH IS SUPERIOR IN TERMS OF SIMPLICITY AND SENSITIVITY OF DETECTION, WORK IN PHASE II WOULD PROCEED TO PERFECTING PRACTICAL ASSAYS AND TO CLONING, EXPRESSING, AND PURIFYING THE LUCIFERASE IN A RECOMBINANT ORGANISM FOR THE PURPOSE OF PROVIDING AN ABUNDANT SUPPLY OF THIS PROTEIN.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.